You are here

Vireo Growth Inc.

Vireo Growth Inc. logo
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
VREO
CSE Index: 
Currency: 

Vireo Growth Inc. is a United States-based multi-state cannabis company with significant operations in our three core markets of Maryland, Minnesota, and New York. We are science-focused and dedicated to providing patients and adult-use customers with high quality cannabis-based products. We cultivate cannabis in environmentally friendly greenhouses, manufacture pharmaceutical-grade cannabis extracts, and sell our products at both Company-owned and third-party dispensaries to qualifying patients and adult-use customers. We currently serve thousands of customers each month.

In addition to the listed Subordinate Voting Shares, there are 347,940 Multiple Voting Shares issued and outstanding. Each Multiple Voting Share is convertible into 100 Subordinate Voting Shares at the option of the holder or upon certain triggering events. This number also includes Subordinate Voting Shares underlying existing and proposed convertible securities.

 

You are here

Vireo Growth Inc. (VREO)

SEDAR Information

Company Info

Address
1500 Royal Centre
1055 West Georgia Street, P.O. Box 11117
Vancouver, BC V6E 4N7
Canada
Email
investor@vireohealth.com
Website
https://www.goodnessgrowth.com
Listing date
Wednesday, March 20, 2019
Transfer Agent
Odyssey Trust Company
Investor Relations
Sam Gibbons
Email
investor@vireohealth.com
Auditor
Davidson & Company LLP

Capitalization

Issued & Outstanding: 
108161130
Reserved for Issuance: 
136887917

Company Officers

Dr. Kyle Kingsley, Executive Chairman
Amber Shimpa, Chief Administrative Officer
James Tyson Macdonald, CFO
John Mazarakis, CEO

Bulletins

04/07/2024

2024-0703 – Name and Symbol Change - Goodness Growth Holdings Inc. (GDNS)

le 4 juillet/July 2023

Goodness Growth Holdings Inc. (GDNS) has announced a name and symbol change to Vireo Growth Inc. (VREO)

Shares will begin trading under the new name and symbol and with a new CUSIP number on July 8, 2024.

Disclosure documents are available at www.thecse.com.